A new therapeutic approach in the medical treatment of Cushing’s syndrome: glucocorticoid receptor blockade with mifepristone.
Fleseriu et al. • 2013 • Endocr Pract. 2013;19(2):313-26.
© 2024 Corcept Therapeutics, Incorporated
Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology.
Baglietto-Vargas et al. • 2013 • Biol Psychiatry. 2013;74(5):357-66.